Hormonal
Semaglutide (both subcutaneous and oral formulations) provides superior glycemic control and greater weight loss compared to other GLP-1 receptor agonists, with demonstrated benefits in reducing major adverse cardiovascular events.
Semaglutide is a highly effective treatment for Type 2 Diabetes, offering better blood sugar control and weight loss than other drugs in its class. It is available as a weekly injection or a daily pill. If you choose the pill, you must take it on an empty stomach with a small sip of water and wait 30 minutes before eating. Start with the lowest dose to minimize stomach upset, which usually goes away. It also helps protect your heart and kidneys.
Semaglutide is an advantageous choice for the treatment of T2D since it has greater efficacy in reducing glycated hemoglobin and body weight compared with other GLP-1RAs, has demonstrated benefits in reducing major adverse cardiovascular events, and has a favorable profile in special populations.
Why this rating
Based on multiple large-scale trials (SUSTAIN, PIONEER, STEP) and CVOTs cited in the review.
Source
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide
Baptist Gallwitz et al. · Frontiers in Endocrinology · 2021
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →